MMP-2 functions as an early response protein in ovarian cancer metastasis - Wikidata - wikimedia - TriplyDB

MMP-2 functions as an early response protein in ovarian cancer metastasis

MMP-2 functions as an early response protein in ovarian cancer metastasis

http://www.wikidata.org/entity/Q33735265

about

The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis Leukotriene B4 receptor-2 promotes invasiveness and metastasis of ovarian cancer cells through signal transducer and activator of transcription 3 (STAT3)-dependent up-regulation of matrix metalloproteinase 2 Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.The IGF-I receptor can alter the matrix metalloproteinase repertoire of tumor cells through transcriptional regulation of PKC-{alpha}.Longitudinal measurement of extracellular matrix rigidity in 3D tumor models using particle-tracking microrheology.Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopy.Ovarian cancer development and metastasis.Motility of select ovarian cancer cell lines: effect of extra-cellular matrix proteins and the involvement of PAK2 Mesenchymal cell interaction with ovarian cancer cells triggers pro-metastatic properties Overexpression of CD157 contributes to epithelial ovarian cancer progression by promoting mesenchymal differentiation.Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1-MMP/MMP2 pathway An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasion.Sensitive surface enhanced Raman scattering multiplexed detection of matrix metalloproteinase 2 and 7 cancer markers.Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer.Matrix metalloproteinase 3 is a stromal marker for chicken ovarian cancer.Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells.Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity Ovarian cancer: involvement of the matrix metalloproteinases.Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.Culture models to define key mediators of cancer matrix remodeling.Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells.Ovarian cancer molecular pathology.Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer.Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.17 β-Estradiol Reverses Leptin-Inducing Ovarian Cancer Cell Migration by the PI3K/Akt Signaling Pathway.Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis.NF-κBP65 promotes invasion and metastasis of oesophageal squamous cell cancer by regulating matrix metalloproteinase-9 and epithelial-to-mesenchymal transition.Knockdown of angiopoietin-2 suppresses metastasis in human pancreatic carcinoma by reduced matrix metalloproteinase-2.Biomarker expression in normal fimbriae: Comparison of high- and low-grade serous ovarian carcinoma.Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.The role of p53 protein and MMP-2 tumor/stromal cells expression on progressive growth of ovarian neoplasms.Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.Coptis japonica Makino extract suppresses angiogenesis through regulation of cell cycle-related proteins.Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness.ADH1B promotes mesothelial clearance and ovarian cancer infiltration.Targeting the Microenvironment in High Grade Serous Ovarian Cancer

P2860

Q26783022-7B039BF3-2C09-449F-BE64-6F2F7F5A2E86 Q28261408-A4A5F22C-7804-4DB0-855B-8158AE40EF64 Q30430565-0FD7F224-BB2A-428D-B1CF-BF53A0119D34 Q30446755-F67902E0-F608-41DF-9423-76A2DA9E2F21 Q33642028-927D49A6-3EBE-4866-8798-1DC4270472C1 Q33872423-7ACA1073-DA08-437C-A2FB-1D7640CF0F73 Q33920939-3306A627-C4ED-4E29-86B7-8CD2165A1B67 Q34086819-7F260488-F288-4740-9FAE-DA6AA16553C7 Q34120393-218D214F-E577-485F-AC8A-AAE33297FA60 Q34292996-4F0BE3B6-F4C6-45DE-A078-4F8131424BEA Q34391763-AD3C1E16-FE38-44ED-A942-4D440396EEBE Q34672640-499E5E2F-6351-45EC-B1D4-5BE334CA5586 Q34868121-BC10BD1B-309E-466A-90CA-890D65846E71 Q35087191-9ACA52FE-E62D-4DB4-9335-2D79ABD40A6C Q35759127-36B61F56-9918-4AC3-BDB4-211940FE490D Q36070842-95C469D4-7ECC-40FC-AC7D-874349F54EE1 Q36121695-A766E074-7107-4BF4-AD09-CAE7F11FCABD Q36179026-D95A3950-DF3E-43C4-9335-536607B8963C Q36199836-74C5748E-7D3F-413B-A8AD-743E64E3BF00 Q36659620-B7A428E8-974F-4D56-899A-E2B2093E4D40 Q37113828-71CE893E-17BE-489A-90BE-7B56A5A0389D Q37196532-D764DE99-8F75-4B04-BAF4-74053B73C807 Q37676502-0DC3DA0C-0255-485D-9D1C-DF57193CB3E5 Q37739569-8CD9E1FC-4E56-4274-B0ED-99F743F70DDC Q38021356-82E487A4-5C05-474C-BBF5-6CD37B066C70 Q38323507-85FCFAB2-9942-4799-B5A0-6ED2560D6116 Q38722425-16A9104C-E439-4A87-AA15-DC0EC5EC21A7 Q38766965-4E38C198-4DA4-4D5D-8358-357ABB6053DD Q39082233-AF0153EB-1110-4DCC-B795-F8587369BC37 Q39179320-7B69F7B6-A6AC-4077-BB90-3E933DE12E2D Q39372556-8B4442A4-923C-4475-A439-5086B78300D1 Q41114714-94578A64-B025-44BB-BD91-757CD806B7A5 Q47114901-2DAA4A0C-2E5D-4BC8-9BF3-4CCEEFEC9904 Q47859831-33438AB5-5424-45DF-9012-4E6C2331F43F Q49658859-599AA707-B025-4C7F-A01F-889605C79A45 Q50874840-19ADD451-B95A-4BAA-A15D-2FC1330FA759 Q53198380-951BEE89-B13E-4D18-AC22-2401245C425B Q53279967-D67BEAEC-86C0-4656-ACFF-0D7C8872F2AE Q55267167-4A03A25F-036D-4AE1-9D60-601A031B406C Q58789499-3F46BF44-7775-44FB-B5CC-4CD87E3006AD

P2860

MMP-2 functions as an early response protein in ovarian cancer metastasis

http://www.wikidata.org/entity/Q33735265

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

MMP-2 functions as an early response protein in ovarian cancer metastasis

@ast

MMP-2 functions as an early response protein in ovarian cancer metastasis

@en

type

label

MMP-2 functions as an early response protein in ovarian cancer metastasis

@ast

MMP-2 functions as an early response protein in ovarian cancer metastasis

@en

prefLabel

MMP-2 functions as an early response protein in ovarian cancer metastasis

@ast

MMP-2 functions as an early response protein in ovarian cancer metastasis

@en

P1433

Q33735265-8FC450D5-1AA4-4296-9B65-4F5D37C27B70

P1476

Q33735265-EA6F0869-1FCE-40A8-BD7E-F032D9BA805D

P2093

Q33735265-7CAD9D16-26CA-47AA-BFCB-0D40CF368D57

Q33735265-C010F116-8BA6-4DA8-8F95-09D6CAE88815

P2860

Q33735265-084BEFDB-2374-445E-B4C2-838E9053078A

Q33735265-09D8A555-F144-4FF1-8FDE-8D0A8B1DD5C1

Q33735265-0C2A378B-8A4B-4FAB-8BA8-FF7626367F86

Q33735265-2290050D-90EF-49CC-9407-8A9EF7ABDC70

Q33735265-30AA912F-1C4B-48FD-BE0E-85B5C7F7EB89

Q33735265-72CC8F51-9CCB-4A1B-B939-E9A49BE9F57A

Q33735265-7E672884-4D38-4C56-9BFC-6113BFDF202B

Q33735265-9BCB8108-048D-4F84-8F96-2E579638695F

Q33735265-9DF89525-61AE-4F3F-A85E-956726A0CD11

Q33735265-B0E8058D-46D9-462A-80FA-C7F71FE1C211

P304

Q33735265-D5ED7A57-2609-411B-AC10-B2FD5E1EFD1F

P31

Q33735265-50235D57-AA10-4421-BB88-F8A57E85B53F

P356

Q33735265-BF6558AF-60D2-4A24-9838-0190DB720390

P433

Q33735265-26ECF600-04DA-4CD5-87BF-B2C56E3A7CC1

P478

Q33735265-E8EF3F8C-9707-44F4-B57E-9918B608DD01

P577

Q33735265-BE7498D4-6C16-415D-817C-6762FE9D84A8

P5875

Q33735265-9E82AF44-8C38-4D1B-A29D-DC0C4362AC97

P698

Q33735265-E39B9D2E-1B78-44E4-9166-41DBF5736EB8

P921

Q33735265-BD0DC6B8-3834-46CA-820A-558DAF125C32

P932

Q33735265-E9502987-DF04-41F8-B275-079E7ADA7ECB

P356

P1433

P1476

MMP-2 functions as an early response protein in ovarian cancer metastasis

@en

P2093

Ernst Lengyel

http://www.w3.org/2001/XMLSchema#string

Hilary A Kenny

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

Ovarian surface epithelium: biology, endocrinology, and pathology

New functions for the matrix metalloproteinases in cancer progression

Composition of the extracellular matrix of the peritoneum.

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.

CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells.

Systematic review of adjuvant care for women with Stage I ovarian carcinoma.

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis

Pathology of the peritoneum: a review of selected topics.

P304

683-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/CC.8.5.7703

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2009-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24019548

http://www.w3.org/2001/XMLSchema#string

P698

19221481

http://www.w3.org/2001/XMLSchema#string

P921

P932

2840625

http://www.w3.org/2001/XMLSchema#string